Author:
Chung Hyun Cheol,Arkenau Hendrik-Tobias,Lee Jeeyun,Rha Sun Young,Oh Do-Youn,Wyrwicz Lucjan,Kang Yoon-Koo,Lee Keun-Wook,Infante Jeffrey R.,Lee Sung Sook,Kemeny Margaret,Keilholz Ulrich,Melichar Bohuslav,Mita Alain,Plummer Ruth,Smith Denis,Gelb Arnold B.,Xiong Huiling,Hong Janet,Chand Vikram,Safran Howard
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Reference31 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
2. NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer. V2.2018. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf . Accessed 15 Oct 2018.
3. NCCN Clinical Practice Guidelines in Oncology. Esophageal and Esophagogastric Junction Cancers. V2.2018. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf . Accessed 15 Oct 2018.
4. Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, et al. PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol. 2013;31:2895–902.
5. Simkens LH, van Tinteren H, May A, ten Tije AJ, Creemers GJ, Loosveld OJ, et al. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch colorectal cancer group. Lancet. 2015;385:1843–52.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献